Evaluation of endocrine changes and insulin release in patients with hereditary spherocytosis
- 12 December 2024
- journal article
- research article
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 61 (2) , 237-240
Abstract
Aim: To evaluate endocrinological changes and insulin secretion in patients with hereditary spherocytosis (HS).Methods: The study included 30 patients with HS and 30 healthy control groups who were of similar age and gender. Routine tests, including hemogram, biochemical and hormonal tests were conducted on both patients with HS and the control group. HOMA‐IR (Homeostasis Model Assessment for Insulin Resistance) and HOMA‐ß% (Homeostasis Model Assessment for ß‐cell function) values of all cases were also calculated using fasting insulin and fasting glucose values.Results: Among the patient group, 7 patients (23.3%) had short stature, 16 patients (53.3%) had vitamin D deficiency, 1 patient (3.3%) had impaired glucose tolerance, 1 patient (3.3%) had subclinical hypothyroidism, 23 patients (76.6%) had dyslipidemia and 2 patients (6.6%) had growth hormone deficiency. The insulin value in the patient group was 4.0 ± 2.7 mlU/mL and significantly lower than the control group with an insulin value of 9.1 ± 3.9 mlU/mL (P < 0.001). Moreover, glucose (P = 0.036), HOMA‐IR (P < 0.001), HOMA‐beta (P < 0.001) and C‐peptide (P = 0.001) values of the patient group were significantly lower than the control group. The cholesterol (P < 0.001), HDL (P < 0.001) and LDL (P < 0.001) values of the patient group were found to be significantly lower than the control group.Conclusion: We found that insulin secretion decreased in patients with HS and hypocholesterolemia occurred due to chronic hemolysis. More research is needed to elucidate the pathophysiology of decreased insulin secretion seen in HS patients.Keywords
This publication has 18 references indexed in Scilit:
- Serum Levels of Cholesterol and Lipoproteins in Patients With Symptomatic Paravalvular LeaksThe American Journal of Cardiology, 2022
- Endocrinal Complications in Children and Adolescents with Thalassemia Major in Central India: An Observational StudyIndian Journal of Pediatrics, 2021
- Insulin Secretion and Resistance in Normoglycemic Patients with Sickle Cell DiseaseHemoglobin, 2017
- Iron and Diabetes RiskCell Metabolism, 2013
- Pancreatic iron and glucose dysregulation in thalassemia majorAmerican Journal of Hematology, 2011
- Traditional laboratory measures of cardiovascular risk in hereditary spherocytosisPediatric Blood & Cancer, 2010
- Therapy Insight: metabolic and endocrine disorders in sickle cell diseaseNature Clinical Practice Endocrinology & Metabolism, 2008
- Lipid profile inβ‐thalassemia intermedia patients: correlation with erythroid bone marrow activityInternational Journal of Laboratory Hematology, 2007
- Reduced insulin secretion in normoglycaemic patients with β‐thalassaemia majorDiabetic Medicine, 2006
- Hypocholesterolemia in children and adolescents with β-thalassemia intermediaThe Journal of Pediatrics, 2002